Search for: "PHARMACIA "
Results 121 - 140
of 174
Sorted by Relevance
|
Sort by Date
5 Jan 2010, 5:37 am
Plaintiff was on hormone therapy, including Provera (manufactured by Pharmacia & Upjohn, owned by Pfizer) for ten years, through three different physicians. [read post]
22 Jan 2010, 12:03 am
"Under the totality of circumstances, which included the facts that none of her prescribing physicians told her there was a causal link between her HRT and breast cancer, and the product information for Provera [a progesterone hormonal substitute manufactured by Pharmacia & Upjohn Co., now owned by Pfizer] was entirely dismissive of any such connection ... it defies logic, contrary to the trial court's suggestion, that appellant [Simon] should have been aware of the risk of… [read post]
27 Aug 2009, 3:48 am
So if a company is headed by a layperson, it can make broader and less reliable claims than Pharmacia can? [read post]
22 Jul 2014, 10:17 am
While AndroGel (Abbvie/Abbott) is one of the most popular of these treatments, they also include: Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/Glaxo) Testopel (Auxilium) The gist of it is that low testosterone treatments may double the risk of heart attack for young men with heart disease as well as for men 65 years of age and older,… [read post]
23 May 2012, 7:51 pm
Pharmacia Corp., 788 A.2d 544 (Del. [read post]
21 Mar 2019, 10:16 am
Abraxis said they were, as there was an important therapeutic differences between the two and thus subject to two different MAs, the latter being the "first MA" (thus complying with Article 3(d)).Mr Justice Arnold considered there was inconsistency in the CJEU judgments as between Neurim and Pharmacia or Yissum. [read post]
5 Jul 2023, 7:33 am
”); Pharmacia Corp. v. [read post]
8 Sep 2020, 2:59 pm
As the Court in the insurance coverage litigation later summarized, the Garber Action alleged that Pfizer, as successor in interest to Pharmacia, had misled investors about the adverse gastrointestinal effects of Celebrex, an anti-inflammatory drug. [read post]
9 Nov 2009, 6:01 am
On the morning of Sept. 2, 2009, another Pfizer unit, Pharmacia & Upjohn, agreed to plead guilty to the same crime. [read post]
26 Feb 2007, 6:59 am
They had been part of the many other Michigan drug companies - Upjohn, Pharmacia, Parke Davis, and Warner Lambert - that had been absorbed by Pfizer. [read post]
9 Jul 2020, 6:16 am
While the CJEU had initially endorsed a restrictive approach in Pharmacia Italia (C-31/03), MIT (C-431/04) and Yissum (C-202/05), it surprisingly made a complete U-turn in the Neurim judgment (C-130/11) rendered in 2012. [read post]
5 Dec 2011, 3:30 am
., Pharmacia Corp., and Pfizer, Inc., alleging that they developed Non–Hodgkins lymphoma after being exposed to polychlorinated biphenyls (PCBs), and asserted claims for strict liability and negligence under California law. [read post]
3 Nov 2014, 11:10 am
Others include: Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) What is the next step? [read post]
21 Jun 2012, 11:46 am
Pharmacia Corporation (f/k/a Monsanto Company)48. [read post]
2 Sep 2011, 5:14 pm
Certiorari stage documents:Opinion below (8th Cir.)Petition for certiorari Brief in oppositionAmicus brief of Pharmacia Corporation et al. [read post]
24 Mar 2009, 7:00 am
Searle and Pharmacia, which are now part of Pfizer). [read post]
3 May 2018, 11:02 am
Pharmacia Biotech, Inc., 225 F.3d 1315 (Fed. [read post]
6 Jul 2011, 2:21 am
Pharmacia & Upjohn in liquidazione and Pfizer Italia s.r.l (Kluwer Patent Blog) US: IPO releases list of top 300 patent holders for 2010 (Patent Docs) US: Supreme Court to hear more patent cases in October 2011 term: Mayo v Prometheus; Kappos v Hyatt; Caraco v Novo Nordisk (Inventive Step) US: In pleading inequitable conduct, inventor’s citation to withheld reference does not establish knowledge of reference sufficient to satisfy FRCP 9(b): Fred Hutchinson Cancer Research Center,… [read post]
9 Jul 2020, 6:16 am
While the CJEU had initially endorsed a restrictive approach in Pharmacia Italia (C-31/03), MIT (C-431/04) and Yissum (C-202/05), it surprisingly made a complete U-turn in the Neurim judgment (C-130/11) rendered in 2012. [read post]
19 Feb 2016, 2:50 pm
RT: [See also the papers in the Xalatan/Travatan case, Pharmacia v. [read post]
